Efficacy and safety of intravenous glucocorticoid therapy for IgG4-related ophthalmic disease.

Min Kyu Yang,Gye Jung Kim,Yeong A Choi,Ho-Seok Sa

PloS one（2023）

引用 0|浏览0

暂无评分

摘要

As a first-line treatment for IgG4-ROD, IV glucocorticoid therapy was well-tolerated, led to better clinical remission and more effectively prevented inflammatory relapse than oral steroids. Further research is needed to establish guidelines on dosage regimens.

查看译文

关键词

intravenous glucocorticoid therapy,ophthalmic disease

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要